M11.10
Familial chondrocalcinosis, unspecified site
Clinical Classification Guidelines
Medical Intelligence & Overview
Familial chondrocalcinosis, classified under ICD-10 code M11.10, is a hereditary joint condition characterized by the abnormal deposition of calcium pyrophosphate dihydrate (CPPD) crystals in cartilage. This condition primarily affects joints and leads to a form of arthritis known as pseudogout. Although the precise cause remains complex, familial chondrocalcinosis is inherited, meaning it runs in families, and can involve multiple joints throughout the body.
Causes & Symptoms
Clinical Causes: Genetic mutations passed down through families influence the development of chondrocalcinosis. Age-related cartilage changes may contribute to or exacerbate crystal formation. Metabolic disorders such as hemochromatosis, hyperparathyroidism, or hypophosphatasia can increase susceptibility. In some cases, the condition appears without an identifiable underlying disorder or genetic link.
Key Symptoms: Joint pain, often sudden and intense, resembling gout attacks. Swelling and warmth around affected joints. Reduced joint mobility and stiffness, particularly after periods of inactivity. Crystalline deposits visible on imaging scans as calcifications within cartilage tissue. Possible joint deformities if the condition persists over many years.
Diagnostic & Treatment
Diagnosis Path: The diagnosis of familial chondrocalcinosis involves a combination of medical history, physical examination, and imaging studies. Key diagnostic steps include: - **Medical history review** focusing on family history of joint problems. - **Physical examination** to assess joint swelling, tenderness, and range of motion. - **Imaging tests** such as X-rays revealing calcification within cartilage tissue, often in multiple joints. - **Synovial fluid analysis** involves extracting joint fluid to identify the presence of calcium pyrophosphate crystals under a microscope. - **Laboratory tests** may be performed to rule out metabolic disorders associated with the condition. Since symptoms can resemble other joint diseases, accurate diagnosis is essential for effective management.
Treatment Protocols: Treatment for familial chondrocalcinosis aims to manage symptoms and prevent joint damage. Approaches include: - **Medications:** Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation during flare-ups. - **Joint injections:** Corticosteroid injections can offer relief in localized inflammation. - **Physical therapy:** Exercises to maintain joint function and strength. - **Lifestyle modifications:** Weight management and avoiding joint stress can minimize symptoms. - **Monitoring and managing underlying metabolic conditions:** Addressing issues like hyperparathyroidism or hemochromatosis may improve outcomes. In some cases, surgical intervention, such as joint replacement, might be necessary if joint damage becomes severe. Regular check-ups and imaging are important for tracking disease progression.
Clinical Advice & FAQs
Billing Guidance
Is M11.10 a billable ICD-10 code?
Yes, M11.10 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M11.10?
Clinical documentation must specify the nature of Familial chondrocalcinosis, unspecified site and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
